Skip to content
Nonprofiteer
← INFECTIOUS DISEASES SOCIETY OF AMERICA INC

Form 990 for tax year 2024

Filed by INFECTIOUS DISEASES SOCIETY OF AMERICA INC.

Totals

Total revenue
$32,259,941
Total expenses
$39,521,191
Contributions and grants received
$1,416,910
Grants paid
$1,060,246
Program service revenue
$28,617,663
Investment income
$1,475,671
Other revenue
$749,697
Total assets, end of year
$66,284,980
Total liabilities, end of year
$17,232,049
Net assets or fund balances, end of year
$49,052,931
Program services expenses (Part IX)
not reported
Management and general expenses
not reported
Fundraising expenses
not reported
Program service expenses (Part III)
not reported

Line items

Every line the filer filed in Parts VIII, IX and X, as filed and in filed order. Blank columns are left out, and the lines are not forced to add up to the totals above.

Revenue

Part VIII, the statement of revenue.

  • 1e · Government grants (contributions)

    $1,131,324

  • 1f · All other contributions, gifts and grants

    $285,586

  • 2a · Program service revenue: ANNUAL MEETING

    total $14,354,523 · related or exempt $14,354,523

  • 2b · Program service revenue: JOURNALS

    total $8,157,653 · related or exempt $8,157,653

  • 2c · Program service revenue: MEMBERSHIP DUES

    total $3,012,730 · related or exempt $2,948,267 · unrelated business $64,463

  • 2d · Program service revenue: MANAGEMENT FEES

    total $2,199,502 · related or exempt $2,199,502

  • 2e · Program service revenue: EDUCATION PROGRAMS

    total $889,755 · related or exempt $889,755

  • 2f · All other program service revenue

    total $3,500 · related or exempt $3,500

  • 3 · Investment income

    total $1,475,671 · excluded $1,475,671

  • 5 · Royalties

    total $552,121 · related or exempt $389,759 · unrelated business $5,000 · excluded $157,362

  • 11a · Other revenue: UNBILLED COSTS

    total $130,587 · excluded $130,587

  • 11b · Other revenue: OTHER REVENUE

    total $66,989 · excluded $66,989

  • 11e · Other revenue, total

    $197,576

Functional expenses

Part IX, the statement of functional expenses.

  • 1 · Grants to domestic organizations and governments

    total $250,000

  • 2 · Grants to domestic individuals

    total $298,167

  • 3 · Grants to foreign organizations and individuals

    total $512,079

  • 5 · Compensation of officers, directors and key employees

    total $2,702,916

  • 7 · Other salaries and wages

    total $10,499,131

  • 8 · Pension plan contributions

    total $598,407

  • 9 · Other employee benefits

    total $881,465

  • 10 · Payroll taxes

    total $876,632

  • 11b · Fees: legal

    total $213,573

  • 11c · Fees: accounting

    total $57,023

  • 11d · Fees: lobbying

    total $576,750

  • 11f · Fees: investment management

    total $162,783

  • 11g · Fees: other

    total $7,944,489

  • 12 · Advertising and promotion

    total $776,818

  • 13 · Office expenses

    total $2,636,112

  • 14 · Information technology

    total $683,399

  • 16 · Occupancy

    total $808,969

  • 17 · Travel

    total $1,526,650

  • 19 · Conferences, conventions and meetings

    total $6,804,342

  • 22 · Depreciation, depletion and amortization

    total $426,092

  • 23 · Insurance

    total $285,394

Balance sheet

Part X, book values.

  • 1 · Cash, non-interest-bearing

    beginning of year $1,030,120 · end of year $2,248,992

  • 2 · Savings and temporary cash investments

    beginning of year $1,685,037 · end of year $1,714,366

  • 4 · Accounts receivable

    beginning of year $3,501,022 · end of year $2,300,038

  • 9 · Prepaid expenses and deferred charges

    beginning of year $745,103 · end of year $928,159

  • 10a · Land, buildings and equipment: cost or other basis

    $3,115,468

  • 10b · Land, buildings and equipment: accumulated depreciation

    $1,602,868

  • 10c · Land, buildings and equipment, net

    beginning of year $1,938,692 · end of year $1,512,600

  • 11 · Investments: publicly traded securities

    beginning of year $46,913,163 · end of year $44,930,525

  • 12 · Investments: other securities

    beginning of year $4,719,232 · end of year $5,078,418

  • 15 · Other assets

    beginning of year $7,572,997 · end of year $7,571,882

  • 17 · Accounts payable and accrued expenses

    beginning of year $2,772,658 · end of year $4,626,755

  • 19 · Deferred revenue

    beginning of year $4,312,114 · end of year $4,322,565

  • 25 · Other liabilities

    beginning of year $9,193,344 · end of year $8,282,729

  • 27 · Net assets without donor restrictions

    beginning of year $51,827,250 · end of year $49,052,931

Mission and programs · 2024

Mission

THE MISSION OF THE INFECTIOUS DISEASES SOCIETY OF AMERICA (IDSA) IS TO IMPROVE THE HEALTH OF INDIVIDUALS, COMMUNITIES, AND SOCIETY BY PROMOTING EXCELLENCE IN PATIENT CARE, EDUCATION, RESEARCH, PUBLIC HEALTH, AND PREVENTION OF INFECTIOUS DISEASES. IDSA'S WORK IS GUIDED BY A COMMITMENT TO SCIENCE, HEALTH EQUITY, AND TACKLING THE CHALLENGES OF INFECTIOUS DISEASES THROUGH ITS GLOBAL COMMUNITY OF EXPERTS.

Activities or mission (Part I)

IMPROVE THE HEALTH OF SOCIETY BY PROMOTING EXCELLENCE IN PATIENT CARE, EDUCATION, RESEARCH, PUBLIC HEALTH AND PREVENTION OF INFECTIOUS DISEASES.

  • IDWEEK ANNUAL CONFERENCE - IDWEEK 2024 IN LOS ANGELES, CA, ATTRACTED MORE THAN 10,000 ATTENDEES. THE MEETING IS THE WORLD'S PREMIER INFECTIOUS DISEASES EVENT. IDWEEK PROVIDES AN OPPORTUNITY FOR HEALTH PROFESSIONALS OF VARIED BACKGROUNDS TO LEARN FROM EACH OTHER'S KNOWLEDGE, EXPERIENCE AND EXPERTISE, FOR THE IMPROVEMENT OF PATIENT CARE AND PUBLIC HEALTH. THIS IS AN INCLUSIVE MEETING THAT OFFERS ACCESS TO INTERNATIONALLY RECOGNIZED LEADERS IN THE FIELD AND THE OPPORTUNITY TO NETWORK WITH THE MOST HIGHLY RESPECTED HEALTH PROFESSIONALS IN INFECTIOUS DISEASES, INCLUDING HIV.

  • CLINICAL INFECTIOUS DISEASES (CID), THE JOURNAL OF INFECTIOUS DISEASES (JID) AND OPEN FORUM INFECTIOUS DISEASES (OFID) ARE SCHOLARLY JOURNALS PUBLISHED BY IDSA IN PARTNERSHIP WITH AN OUTSIDE PUBLISHER TO DISSEMINATE THE LATEST RESEARCH ON A VARIETY OF TOPICS IN THE FIELD TO MEMBERS AND SUBSCRIBERS. CID PUBLISHES ORIGINAL RESEARCH, REVIEWS AND PERSPECTIVES THAT ALL CLINICIANS CAN USE WHEN CARING FOR PATIENTS. CID COVERS THE CLINICAL PRESENTATION, DIAGNOSIS, TREATMENT AND PREVENTION OF THE FULL RANGE OF INFECTIOUS DISEASES. THE EVALUATION OF CURRENT AND NOVEL TREATMENTS, MICROBIOLOGY, IMMUNOLOGY AND POLICIES AS THEY RELATE TO PATIENT CARE ARE HIGHLY PRIORITIZED. PUBLISHED CONTINUOUSLY SINCE 1904, JID IS THE PREMIER GLOBAL JOURNAL FOR TRANSLATIONAL INFECTIOUS DISEASES SCIENCE. THE EDITORS WELCOME MAJOR ARTICLES AND BRIEF REPORTS DESCRIBING RESEARCH RESULTS ON MICROBIOLOGY, IMMUNOLOGY, EPIDEMIOLOGY, AND RELATED DISCIPLINES, ON THE PATHOGENESIS, DIAGNOSIS, AND TREATMENT OF INFECTIOUS DISEASES; ON THE MICROBES THAT CAUSE THEM; AND ON DISORDERS OF HOST IMMUNE RESPONSES. OFID PUBLISHES CLINICAL, TRANSLATIONAL AND BASIC RESEARCH IN A FULLY OPEN ACCESS, ONLINE JOURNAL. IT FOCUSES ON THE INTERSECTION OF BIOMEDICAL SCIENCE AND CLINICAL PRACTICE, WITH AN EMPHASIS ON KNOWLEDGE THAT COULD IMPROVE PATIENT CARE GLOBALLY. ARTICLES ARE WRITTEN BY EXPERTS IN THE FIELD, INCLUDING MEMBERS AND NON-MEMBERS, AND REVIEWED BY A PANEL OF LEADING MEDICAL EXPERTS BEFORE THEY ARE PUBLISHED.

  • MEMBER SERVICES - IDSA MEMBER SERVICES PROVIDES TIMELY SCIENTIFIC INFORMATION, RELEVANT PUBLIC POLICY AND REGULATION, AND CAREER DEVELOPMENT RESOURCES.

  • IDSA WAS AWARDED A COOPERATIVE AGREEMENT TO SUPPORT THE CDC BY PROVIDING RESOURCES TO FRONTLINE HEALTH CARE PROFESSIONALS CARING FOR PATIENTS WITH COVID-19. THE PARTNERSHIP BRINGS NUMEROUS MEDICAL SPECIALTIES TOGETHER TO SHARE RESOURCES AND TO PROVIDE THE LATEST INFORMATION AND GUIDANCE ON TREATING THOSE INFECTED WITH COVID-19 AND PREVENTING ITS SPREAD. THROUGH FUNDING FROM CDC, IDSA EXPERTS SUPPORT CDC'S CLINICAL CALL LINES, PROVIDING GUIDANCE TO HEALTH CARE PROVIDERS TREATING COVID-19 PATIENTS. THE COLLABORATION HAS ALSO FUNDED THE FLOURISHING COVID-19 REAL-TIME LEARNING NETWORK, AN ONLINE CENTER FOR FRONTLINE CLINICIANS TO LEARN, COLLABORATE AND SHARE TREATMENT BEST PRACTICES. IDSA'S COVID-19 PRACTICE GUIDELINES ON DIAGNOSTICS, TREATMENT AND MANAGEMENT ALSO RECEIVE FUNDING THROUGH THE GRANT. ADDITIONALLY, UNDER THE PARTNERSHIP, TWICE-MONTHLY CLINICIAN TELECONFERENCES PROVIDE HEALTH CARE PROFESSIONALS ACCESS TO EXPERTS WITH THE LATEST INFORMATION ON THIS EVOLVING VIRUS AS WELL AS AN OPPORTUNITY TO ASK QUESTIONS. THE CALLS FREQUENTLY DRAW MORE THAN 800 ATTENDEES.

As filed on the 2024 return. The filer continues this part on Schedule O, which is not shown here.

Listed in Part VII

  • Christopher Busky Cae

    CHIEF EXECUTIVE OFFICER

    Total calculated
    $813,135
    From this org
    $711,141
    From related orgs
    $15,664
    Other
    $86,330
    Hours/week
    32.5 + 5 related

    Schedule J breakdown matched by us

    Base
    $571,733 + $15,664 related
    Bonus
    $123,744
    Other
    $15,664
    Deferred
    $48,820 + $1,338 related
    Nontaxable benefits
    $35,207 + $965 related
    Filer's total
    $795,168 + $17,967 related

  • Ty Johnson

    CHIEF OPERATING OFFICER

    Total calculated
    $470,589
    From this org
    $326,268
    From related orgs
    $104,406
    Other
    $39,915
    Hours/week
    22.5 + 15 related

    Schedule J breakdown matched by us

    Base
    $221,862 + $104,406 related
    Bonus
    $0
    Other
    $104,406
    Deferred
    $16,629 + $7,825 related
    Nontaxable benefits
    $10,513 + $4,948 related
    Filer's total
    $353,410 + $117,179 related

  • Dana Wollins

    SVP, STRATEGY

    Total calculated
    $344,657
    From this org
    $284,741
    From related orgs
    $0
    Other
    $59,916
    Hours/week
    37.5

    Schedule J breakdown matched by us

    Base
    $284,741
    Bonus
    $0
    Other
    $0
    Deferred
    $22,181
    Nontaxable benefits
    $37,735
    Filer's total
    $344,657

  • Amanda Jezek

    SVP, POLICY & GOVERNMENT RELATIONS

    Total calculated
    $330,109
    From this org
    $273,303
    From related orgs
    $0
    Other
    $56,806
    Hours/week
    37.5

    Schedule J breakdown matched by us

    Base
    $273,303
    Bonus
    $0
    Other
    $0
    Deferred
    $21,000
    Nontaxable benefits
    $35,806
    Filer's total
    $330,109

  • Sandra Vura Harwood

    VP, MEETINGS & EDUCATION

    Total calculated
    $306,752
    From this org
    $262,084
    From related orgs
    $0
    Other
    $44,668
    Hours/week
    37.5

    Schedule J breakdown matched by us

    Base
    $262,084
    Bonus
    $0
    Other
    $0
    Deferred
    $17,983
    Nontaxable benefits
    $26,685
    Filer's total
    $306,752

  • Felicity Clancy

    VP, MARKETING & MEMBERSHIP

    Total calculated
    $297,666
    From this org
    $242,469
    From related orgs
    $0
    Other
    $55,197
    Hours/week
    37.5

    Schedule J breakdown matched by us

    Base
    $242,469
    Bonus
    $0
    Other
    $0
    Deferred
    $16,741
    Nontaxable benefits
    $38,456
    Filer's total
    $297,666

  • Andrea Weddle

    ED, HIVMA

    Total calculated
    $278,957
    From this org
    $239,037
    From related orgs
    $6,374
    Other
    $33,546
    Hours/week
    36.5 + 1 related

    Schedule J breakdown matched by us

    Base
    $232,663 + $6,374 related
    Bonus
    $0
    Other
    $6,374
    Deferred
    $17,702 + $485 related
    Nontaxable benefits
    $14,949 + $410 related
    Filer's total
    $271,688 + $7,269 related

  • Salandra Thomas

    VP, TALENT & ORG. DEVELOPMENT

    Total calculated
    $280,649
    From this org
    $228,380
    From related orgs
    $6,090
    Other
    $46,179
    Hours/week
    34.5 + 3 related

    Schedule J breakdown matched by us

    Base
    $222,290 + $6,090 related
    Bonus
    $0
    Other
    $6,090
    Deferred
    $17,236 + $472 related
    Nontaxable benefits
    $27,712 + $759 related
    Filer's total
    $273,328 + $7,321 related

  • Barton Groh

    VP, FINANCE & ADMINISTRATION

    Total calculated
    $283,621
    From this org
    $223,970
    From related orgs
    $11,945
    Other
    $47,706
    Hours/week
    30.5 + 7 related

    Schedule J breakdown matched by us

    Base
    $212,025 + $11,945 related
    Bonus
    $0
    Other
    $11,945
    Deferred
    $16,540 + $932 related
    Nontaxable benefits
    $28,622 + $1,612 related
    Filer's total
    $269,132 + $14,489 related

  • Rachel Shnekendorf

    SENIOR DIRECTOR, EDUCATION

    Total calculated
    $206,620
    From this org
    $179,665
    From related orgs
    $0
    Other
    $26,955
    Hours/week
    37.5

    Schedule J breakdown matched by us

    Base
    $179,665
    Bonus
    $0
    Other
    $0
    Deferred
    $13,574
    Nontaxable benefits
    $13,381
    Filer's total
    $206,620

  • Jennifer Morales

    SENIOR DIRECTOR, PR & MARKETING

    Total calculated
    $207,428
    From this org
    $177,935
    From related orgs
    $0
    Other
    $29,493
    Hours/week
    37.5

    Schedule J breakdown matched by us

    Base
    $177,935
    Bonus
    $0
    Other
    $0
    Deferred
    $13,631
    Nontaxable benefits
    $15,862
    Filer's total
    $207,428

  • Gayle Levy Hartman

    SENIOR DIRECTOR, DIGITAL & CONTENT STRATEGY

    Total calculated
    $222,657
    From this org
    $169,138
    From related orgs
    $0
    Other
    $53,519
    Hours/week
    37.5

    Schedule J breakdown matched by us

    Base
    $169,138
    Bonus
    $0
    Other
    $0
    Deferred
    $13,675
    Nontaxable benefits
    $39,844
    Filer's total
    $222,657

  • Steven K Schmitt MD

    IMMED. PAST PRESIDENT AS OF 10/2024

    Total calculated
    $25,000
    From this org
    $25,000
    From related orgs
    $0
    Other
    $0
    Hours/week
    2

  • Tina Q Tan MD

    PRESIDENT AS OF 10/2024

    Total calculated
    $7,500
    From this org
    $7,500
    From related orgs
    $0
    Other
    $0
    Hours/week
    2 + 0.5 related

  • Carlos Del Rio MD

    IMMED. PAST PRESIDENT UNTIL 10/2024

    Total calculated
    $0
    Hours/week
    2

  • Ronald Nahass MD

    PRESIDENT ELECT AS OF 10/2024

    Total calculated
    $0
    Hours/week
    2 + 0.5 related

  • Wendy S Armstrong MD

    VICE PRESIDENT AS OF 10/2024

    Total calculated
    $0
    Hours/week
    2 + 0.5 related

  • Maximo Brito MD

    TREASURER

    Total calculated
    $0
    Hours/week
    2 + 0.5 related

  • Robin Trotman MD

    SECRETARY

    Total calculated
    $0
    Hours/week
    2

  • Erin Bonura MD

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1

  • Robin Henry Dretler MD

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1

  • Matifadza Hlatshwayo Davis MD MPH

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1

  • Heather C Yun MD

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1

  • Bonnie M Word MD

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1

  • David Aronoff MD

    DIRECTOR AS OF 10/2024

    Total calculated
    $0
    Hours/week
    1

  • Upinder Singh MD

    DIRECTOR AS OF 10/2024

    Total calculated
    $0
    Hours/week
    1

  • Rajesh T Ghandi MD

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1

  • Kami Kim MD

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1

Compensation is as filed in Part VII: reportable pay from this organization and from related organizations, other compensation, and hours per week. The total, marked calculated, is our sum of the three dollar columns, with a blank column counted as $0; the form itself has no total. On a Form 990-EZ the columns are Part IV's instead, and on a Form 990-PF Part VIII's — compensation, contributions to benefit plans, and expense account — and the total sums those. A Schedule J breakdown is as filed: base pay, bonus, other, deferred compensation and nontaxable benefits from this organization, with any from related organizations beside each, and the filer's own total. It is shown with the Part VII listing of the same name on the same return. The form gives no key between the two, so that pairing is ours, and is marked matched by us.

Schedule J

Answered yes

  • 3 · Form 990 of other organizations
  • 3 · Written employment contract
  • 3 · Compensation survey or study
  • 3 · Approval by the board or compensation committee
  • 4b · Supplemental nonqualified retirement plan

Answered no

  • 4a · Severance or change-of-control payment
  • 4c · Equity-based compensation arrangement

The filer's explanations (Part III)

PART I, LINE 3
CEO COMPENSATION: THE IDSA BOARD HAS ENTERED INTO AN EMPLOYMENT CONTRACT WITH ITS CHIEF EXECUTIVE OFFICER. THE COMPENSATION DETAILED IN THE CONTRACT AND SUBSEQUENT RAISES DURING THE CONTRACT TERM ARE BASED ON A REVIEW OF 990'S FROM OTHER SIMILAR NON-PROFIT ORGANIZATIONS, A COMPENSATION STUDY WRITTEN EMPLOYMENT CONTRACTS OF OTHER SIMILARILY SITUATED EXCECUTIVES, AND ANNUAL APPROVAL BY THE EXECUTIVE COMMITTEE.
PART I, LINE 4B
THE ORGANIZATION CONTRIBUTED $29,232 TO 457 PLANS FOR THE BENEFIT OF THE CEO.

Part I's answers as filed. A line not listed was left unanswered; on lines 1a and 3 that means the box was not checked.

Grants on this return

Related organizations on this return

Schedule R Part II: tax-exempt organizations related to the filer by control. It does not record shared board members or money.

  • IDSA EDUCATION AND RESEARCH FOUNDATION

    501(C)(3) · FUNDING INITIATIVES DEDICATED TO SUPPORTING IDSA'S MISSION WORLDWIDE · VA · controlled entity

    Directly controlled by INFECTIOUS DISEASES SOCIETY OF AMERICA

Provenance

Return type
form_990
Tax year
2024
Filed
11 November 2025
IRS schema version
2024v5.2
Source object
202543179349301589

Check it against the return as filed: the GivingTuesday Data Lake hosts a public copy of the original XML.

The source document this was parsed from is served over the API, which is where bulk and document access live.